Also the activation of NF-κB, which is the downstream gene of TLR4, contributed to mammary epithelial tumor progression in vivo. Inhibition of NF-κB led to the decreased tumor burden and decreased numbers of lung metastases [34]. The gene discussed is NFKB1; the disease is neoplasm.